Innoviva
INVA
#4983
Rank
โ‚ฌ1.43 B
Marketcap
19,20ย โ‚ฌ
Share price
0.27%
Change (1 day)
19.17%
Change (1 year)

Earnings for Innoviva (INVA)

Earnings in 2025 (TTM): โ‚ฌ0.13 Billion

According to Innoviva's latest financial reports the company's current earnings are โ‚ฌ0.38 Billion. In 2024 the company made an earning of โ‚ฌ32.58 Million a decrease over its 2023 earnings that were of โ‚ฌ0.16 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Innoviva from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚ฌ0.13 B308.19%
2024 โ‚ฌ32.58 M-80.74%
2023 โ‚ฌ0.16 B-32.36%
2022 โ‚ฌ0.25 B-35.56%
2021 โ‚ฌ0.38 B25.7%
2020 โ‚ฌ0.30 B52.11%
2019 โ‚ฌ0.20 B10.77%
2018 โ‚ฌ0.18 B56.59%
2017 โ‚ฌ0.11 B125.53%
2016 โ‚ฌ51.88 M-417.36%
2015 -โ‚ฌ16.35 Million-74.49%
2014 -โ‚ฌ64.09 Million-25.19%
2013 -โ‚ฌ85.66 Million430.06%
2012 -โ‚ฌ16.16 Million-83.92%
2011 -โ‚ฌ0.11 Billion39.82%
2010 -โ‚ฌ71.9 Million2.84%
2009 -โ‚ฌ69.91 Million-8.62%
2008 -โ‚ฌ76.51 Million-47.92%
2007 -โ‚ฌ0.15 Billion-5.92%
2006 -โ‚ฌ0.16 Billion19.8%
2005 -โ‚ฌ0.14 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-โ‚ฌ0.14 Billion-201.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-โ‚ฌ15.83 Million-111.60%๐Ÿ‡บ๐Ÿ‡ธ USA